MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 6.88
+0.06 (0.88%)
At close: Mar 13, 2026
MaaT Pharma Market Cap
MaaT Pharma has a market cap or net worth of €129.46 million as of March 13, 2026. Its market cap has increased by 47.95% in one year.
Market Cap
129.46M
Enterprise Value
128.83M
Revenue
3.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.88
Market Cap Chart
Since November 8, 2021, MaaT Pharma's market cap has decreased from 132.73M to 129.46M, a decrease of -2.47%. That is a compound annual growth rate of -0.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 129.46M | 67.12% |
| Dec 31, 2025 | 77.47M | -29.96% |
| Dec 31, 2024 | 110.61M | 36.57% |
| Dec 29, 2023 | 80.99M | 2.32% |
| Dec 30, 2022 | 79.15M | -40.01% |
| Dec 31, 2021 | 131.95M | -0.59% |
| Nov 8, 2021 | 132.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genfit | 422.76M |
| Cellectis | 227.82M |
| Transgene | 213.59M |
| Sensorion | 198.23M |
| Innate Pharma | 117.16M |
| Adocia | 116.19M |
| ABIONYX Pharma | 115.18M |
| OSE Immunotherapeutics | 82.51M |